Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for OAB Secondary to Benign Prostatic Obstruction
NCT00479596Phase 3Unknown
- Sponsor
- Urological Sciences Research Foundation
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Urological Sciences Research Foundation. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00479596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479596.